John Catalano

Adj ClinAssProf

19982018
If you made any changes in Pure these will be visible here soon.

Research Output 1998 2018

Filter
Letter
2018

Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia

Tiong, I. S., Tan, P., McManus, J., Cummings, N., Sadawarte, S., Catalano, J., Hills, R. & Wei, A., 2018, In : Leukemia and Lymphoma. 59, 2, p. 493-496 4 p.

Research output: Contribution to journalLetterResearchpeer-review

2015
15 Citations (Scopus)

Impact of maintenance therapy on subsequent treatment in patients with newly diagnosed multiple myeloma: Use of “progression-free survival 2” as a clinical trial end-point

Dimopoulos, M. A., Petrucci, M. T., Foà, R., Catalano, J., Kropff, M., Terpos, E., Zhang, J., Grote, L., Jacques, C. & Palumbo, A., 5 Aug 2015, In : Haematologica: the hematology journal. 100, 8, p. e328-e330 3 p.

Research output: Contribution to journalLetterResearchpeer-review

Open Access